These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26187236)

  • 21. Targeted therapy: A novel approach in head and neck cancer.
    Christy AW; Bojan A
    Indian J Dent Res; 2013; 24(2):261-6. PubMed ID: 23965459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial.
    Martins RG; Parvathaneni U; Bauman JE; Sharma AK; Raez LE; Papagikos MA; Yunus F; Kurland BF; Eaton KD; Liao JJ; Mendez E; Futran N; Wang DX; Chai X; Wallace SG; Austin M; Schmidt R; Hayes DN
    J Clin Oncol; 2013 Apr; 31(11):1415-21. PubMed ID: 23460709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of 'in-field' skin toxicity in head and neck cancer patients treated with combined cetuximab and radiotherapy.
    Cante D; La Porta MR; Franco P; Sciacero P; Girelli GF; Marra A; Numico G; Denaro N; Russi EG; Ricardi U
    Oncology; 2013; 85(5):257-61. PubMed ID: 24192693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab.
    Bölke E; Gerber PA; Lammering G; Peiper M; Müller-Homey A; Pape H; Giro C; Matuschek C; Bruch-Gerharz D; Hoffmann TK; Gripp S; Homey B; Budach W
    Strahlenther Onkol; 2008 Feb; 184(2):105-10. PubMed ID: 18259703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck.
    Koyfman SA; Cooper JS; Beitler JJ; Busse PM; Jones CU; McDonald MW; Quon H; Ridge JA; Saba NF; Salama JK; Siddiqui F; Smith RV; Worden F; Yao M; Yom SS
    Head Neck; 2016 Feb; 38(2):175-82. PubMed ID: 26791005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of combined treatment with cetuximab (erbitux) and radiation therapy in patients with head and neck cancer.
    Koukourakis G; Kouloulias V; Koukourakis M; Kouvaris J; Zacharias G; Gouliamos A
    J BUON; 2009; 14(1):19-25. PubMed ID: 19373942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptor (EGFR) expression and mutations in the EGFR signaling pathway in correlation with anti-EGFR therapy in head and neck squamous cell carcinomas.
    Smilek P; Neuwirthova J; Jarkovsky J; Dusek L; Rottenberg J; Kostrica R; Srovnal J; Hajduch M; Drabek J; Klozar J
    Neoplasma; 2012; 59(5):508-15. PubMed ID: 22668015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cetuximab with radiotherapy in patients with loco-regionally advanced squamous cell carcinoma of head and neck unsuitable or ineligible for concurrent platinum-based chemo-radiotherapy: Ready for routine clinical practice?
    Agarwal JP; Gupta T; Kalyani N; Budrukkar A; Laskar SG; Murthy V; Kumar P; Narohna V; Pai P; Chaturvedi P; D'cruz AK
    Indian J Cancer; 2011; 48(2):148-53. PubMed ID: 21768657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiotherapy combined with cetuximab for locally advanced head and neck cancer: results and toxicity.
    Acevedo-Henao CM; Valette G; Miglierini P; Lefur E; Pradier O
    Cancer Radiother; 2012 Oct; 16(7):601-3. PubMed ID: 23089070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive treatment of squamous cell cancer of head and neck: Chinese expert consensus 2013.
    Lang J; Gao L; Guo Y; Zhao C; Zhang C; ; ;
    Future Oncol; 2014; 10(9):1635-48. PubMed ID: 24635574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted therapies in squamous cell carcinoma of the head and neck.
    Gold KA; Lee HY; Kim ES
    Cancer; 2009 Mar; 115(5):922-35. PubMed ID: 19156911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT.
    Studer G; Brown M; Salgueiro EB; Schmückle H; Romancuk N; Winkler G; Lee SJ; Sträuli A; Kissling B; Dummer R; Glanzmann C
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):110-7. PubMed ID: 20732757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer.
    Lartigau EF; Tresch E; Thariat J; Graff P; Coche-Dequeant B; Benezery K; Schiappacasse L; Degardin M; Bondiau PY; Peiffert D; Lefebvre JL; Lacornerie T; Kramar A
    Radiother Oncol; 2013 Nov; 109(2):281-5. PubMed ID: 24262821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update.
    Bernier J
    Curr Opin Oncol; 2008 May; 20(3):249-55. PubMed ID: 18391622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding role of the medical oncologist in the management of head and neck cancer.
    Choong N; Vokes E
    CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.
    Driessen CM; de Boer JP; Gelderblom H; Rasch CR; de Jong MA; Verbist BM; Melchers WJ; Tesselaar ME; van der Graaf WT; Kaanders JH; van Herpen CM
    Eur J Cancer; 2016 Jan; 52():77-84. PubMed ID: 26655558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?
    Bourhis J; Lefebvre JL; Vermorken JB
    Eur J Cancer; 2010 Jul; 46(11):1979-89. PubMed ID: 20561781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology.
    Russi EG; Corvò R; Merlotti A; Alterio D; Franco P; Pergolizzi S; De Sanctis V; Ruo Redda MG; Ricardi U; Paiar F; Bonomo P; Merlano MC; Zurlo V; Chiesa F; Sanguineti G; Bernier J
    Cancer Treat Rev; 2012 Dec; 38(8):1033-49. PubMed ID: 22542950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gel of chamomile vs. urea cream to prevent acute radiation dermatitis in patients with head and neck cancer: a randomized controlled trial.
    Ferreira EB; Ciol MA; Vasques CI; Bontempo Pde S; Vieira NN; Silva LF; Avelino SR; Dos Santos MA; Dos Reis PE
    J Adv Nurs; 2016 Aug; 72(8):1926-34. PubMed ID: 27020698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging molecular targeted therapies in the treatment of head and neck cancer.
    Bozec A; Peyrade F; Fischel JL; Milano G
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):299-310. PubMed ID: 19519286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.